Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence

NCT00003858 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study was not activated.

Conditions

Prostate Cancer

Interventions

DRUG: mitoxantrone hydrochloride

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]